Sanjivani Paranteral LtdPharmaceuticalsINE860D01013Standalone₹179.80-1.00 (-0.55%)Jun-26
Valuation
Market Cap₹220.87 Cr
TTM PE29.33x
Forward PE28.09x
PEG0.67
Book Value₹30.93
P/B5.81x
TTM EPS₹6.13
Fwd EPS₹6.40
TTM Revenue₹66.33 Cr
TTM PAT₹7.50 Cr
TTM EBITDA₹10.15 Cr
TTM EBIT₹9.13 Cr
Last Qtr PAT₹2.30 Cr
Last Qtr EBITDA₹3.40 Cr
Last Qtr EBIT₹3.09 Cr
Profitability
ROE19.74%
ROCE23.00%
TTM NPM11.31%
TTM EBITDA %15.30%
Curr OPM11.79%
Last OPM8.91%
Curr NPM—
Last NPM—
Curr EPS₹1.87
Last EPS₹0.80
Balance sheet
Equity₹11.88 Cr
Reserve₹26.11 Cr
Total Debt₹8.14 Cr
D/E0.21x
Interest %7.83%
Curr Interest₹0.18 Cr
Price / range
Close₹179.80
vs 52W High-31.88%
vs 52W Low+42.70%
MA50—
MA200—
Returns
1D-0.55%
1W-0.47%
1M-10.53%
3M+21.57%
6M+14.16%
1Y-24.91%
2Y-42.52%
3Y+71.24%
5Y+481.88%
Diwali-21.28%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits